COVID-19: Clinical Presentations and Spectrum of Imaging Findings Online Course
This course will provide a well-rounded overview of the origin, pathophysiology, and varied clinical presentations of COVID-19 infection. Through illustrative case examples, the spectrum of radiologic imaging findings affecting the lungs, heart, gastrointestinal systems, and central nervous system in adult patients and the manifestations of the recently reported Multisystem Inflammatory Syndrome in Children (MIS-C) will be highlighted. strong>
The target audience for this activity is radiologists, radiologists in-training, primary health care providers, and critical care medicine attending and fellows with an interest in image findings of COVID-19 infection.
Goals and Objectives:
After completing the material in this activity, the learner should be able to:
Discuss how SARS-CoV-2 first emerged and eventually resulted in the COVID-19 worldwide pandemic
Describe the interaction between the COVID-19 spike glycoproteins and the ACE-2 receptors allowing its entry into the body resulting in multisystem organ infection
Analyze typical and atypical chest radiographic and CT manifestations of COVID-19, how to generate a standardized chest X-ray and or CT report and the position of major radiology societies on the use of imaging in the COVID-19 pandemic
Assess hysiologic benefits and diagnostic interpretive challenges associated with the use prone ventilation and radiographic imaging in COVID-19 patients with hypoxemic respiratory failure
Assess pulmonary complications of COVID-19 including heightened risk of barotrauma, pulmonary thromboembolic disease and more long-term chronic pulmonary sequelae of the infection
Assess the various myocardial imaging findings, presentations and complications associated with COVID-19 infection
Assess the various abdominal imaging findings, presentations and complications associated with COVID-19 infection
Assess various central neurologic complications of COVID-19 infection including encephalopathy, acute disseminated encephalomyelitis, thrombotic vascular events such as stroke; peripheral nervous systems manifestations such as dysgeusia, Guillain-Barre syndrome and post infection brain fog
Describe what the radiologists needs to know about COVID-19 related Multisystem Inflammatory Syndrome in Children (MISC) and the International Expert Consensus Statement on Chest Imaging in Pediatric COVID-19
Discuss the role Artificial Intelligence may play in the diagnosis, management and treatment of patients infected with COVID-19
Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners’ disclosures:
Kerry Husk Davis has nothing to disclose.
Jeremiah Long has nothing to disclose.
Courtney Moreno has nothing to disclose.
Christopher Neumann has nothing to disclose.
Mark Parker has nothing to disclose.
Puneet Belani has nothing to disclose.
Rajesh Bhayana has nothing to disclose.
Aamer Chughtai has nothing to disclose.
Shaimaa Fadl has nothing to disclose.
Edward Lee has nothing to disclose.
John Leyendecker has nothing to disclose.
Diana Litmanovich has nothing to disclose.
Georgeann McGuiness has nothing to disclose.
Mark Parker has nothing to disclose.
Carlo De Cecco is a recipient of a research grant from Siemens. He also receives a speaker fee from Bayer.
Accreditation Statement The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement The ARRS designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.